- Safeway confirms grocer is exploring possible sale
- Albertsons to acquire Safeway in deal worth more than $9.1 billion to Safeway shareholders
- Senate passes Drug Quality and Security Act
- Study: Cough-cold manufacturers' voluntary label change on pediatric products reduced ER admissions
- Study: 2,000 IUs of vitamin E daily effective in slowing functional decline in AD patients
PLEASANTON, Calif. — After ending its five-week fundraising campaign to benefit the Muscular Dystrophy Association's efforts to develop treatments and assist people coping with neuromuscular diseases, Safeway announced that its stores raised $10.4 million for the organization.
The campaign, which ran from Aug. 1 through Labor Day, marked Safeway's 10th annual fundraising effort. Safeway has raised more than $58 million for muscular dystrophy charities.
"We are grateful to our customers and employees for their support and commitment to helping MDA find cures for some of the most debilitating diseases that face medical science," said Larree Renda, EVP and chair of the Safeway Foundation. "The funds we raised will support medical advances as well as services and therapies designed to help people with neuromuscular disease."